Vilniaus Degtine AB:企業の戦略・SWOT・財務情報

◆英語タイトル:Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3895
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:リトアニア
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Vilniaus Degtine AB – Strategy, SWOT and Corporate Finance Report
Summary

Vilniaus Degtine AB – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vilniaus Degtine AB (Vilniaus Degtine), a subsidiary of Marie Brizard Wine & Spirits, is principally involved in the production and sale of alcoholic beverages in Lithuania and internationally. Its product portfolio includes vodka, bitter, liqueur, brandy, gin, rum, balsam and other related alcoholic drinks. The major brands of the company include Bajorų, Sobieski, Renaissance, Gedimino“,Čepkelių, Starka William Peel, Gautier, Marie Brizard, and Sobieski, to name a few. Vilniaus Degtine also manufactures distilled food grade ethyl alcohol from rye and triticale. It exports products to Latvia, Poland, Estonia, France, Azerbaijan, China, Denmark, Israel, Ukraine, Spain and the US. The company owns a cogeneration power plant for the heat and electricity production. Vilniaus Degtine is headquartered in Vilnius, Lithuania

Scope

- Detailed information on Vilniaus Degtine AB required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vilniaus Degtine AB in the form of a SWOT analysis
- An in-depth view of the business model of Vilniaus Degtine AB including a breakdown and examination of key business segments
- Intelligence on Vilniaus Degtine AB’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vilniaus Degtine AB, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vilniaus Degtine AB and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vilniaus Degtine AB as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vilniaus Degtine AB’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Vilniaus Degtine AB: Company Overview 8
Vilniaus Degtine AB: Overview and Key Facts 8
Vilniaus Degtine AB: Overview 8
Vilniaus Degtine AB: Key Facts 8
Vilniaus Degtine AB: Key Employees 10
Vilniaus Degtine AB: Major Products and Services 11
Vilniaus Degtine AB: Company History 12
Vilniaus Degtine AB: Management Statement 13
Vilniaus Degtine AB: Locations and Subsidiaries 14
Vilniaus Degtine AB: Key Competitors 15
Vilniaus Degtine AB: Company Analysis 16
Vilniaus Degtine AB: Business Description 16
Vilniaus Degtine AB: SWOT Analysis 17
Vilniaus Degtine AB: SWOT Overview 17
Vilniaus Degtine AB: Strengths 17
Vilniaus Degtine AB: Weaknesses 18
Vilniaus Degtine AB: Opportunities 18
Vilniaus Degtine AB: Threats 19
Vilniaus Degtine AB: Corporate Financial Deals Activity 20
Vilniaus Degtine AB: Financial Deals Overview 20
Vilniaus Degtine AB: Top Deals 2014 – 2018YTD* 21
Vilniaus Degtine AB: Private Equity and Ownership 22
Vilniaus Degtine AB: Recent Developments 23
Vilniaus Degtine AB: News and Events Summary 23
Vilniaus Degtine AB: Corporate Governance 23
Appendix 25
Contact Us 25
Methodology 25
About MarketLine 26

List of Tables
Table 1: Vilniaus Degtine AB: Key Facts
Table 2: Vilniaus Degtine AB: Key Employees
Table 3: Vilniaus Degtine AB: Locations and Subsidiaries
Table 4: Vilniaus Degtine AB: Key Competitors
Table 5: Vilniaus Degtine AB: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Vilniaus Degtine AB: Top Deals 2014 - 2018YTD*
Table 7: Vilniaus Degtine AB: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 8: Vilniaus Degtine AB: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 9: Vilniaus Degtine AB: News and Events Summary
Table 10: Vilniaus Degtine AB: Corporate Governance

List of Figures
Figure 1: Vilniaus Degtine AB: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Vilniaus Degtine AB: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 3: Vilniaus Degtine AB: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Vilniaus Degtine AB:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Antibe Therapeutics Inc (ATE)-製薬・医療分野:企業M&A・提携分析
    Summary Antibe Therapeutics Inc (Antibe) is a biotechnology company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercialize novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen …
  • Owens & Minor Inc (OMI):医療機器:M&Aディール及び事業提携情報
    Summary Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and su …
  • Salk Institute for Biological Studies-製薬・医療分野:企業M&A・提携分析
    Summary Salk Institute for Biological Studies (Salk) is a research institute that offers biological research programs. The institute’s areas of research comprise molecular biology and genetics, neurosciences, and plant biology. Its research provides development of new therapies and treatments for di …
  • Time Dotcom Berhad (TIMECOM):企業の財務・戦略的SWOT分析
    Time Dotcom Berhad (TIMECOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ultimovacs AS-製薬・医療分野:企業M&A・提携分析
    Summary Ultimovacs AS (Ultimovacs) is a provider of novel immunotherapies for cancer treatment. The company develops synthetic peptide based therapeutic vaccines that can be used on its own and also in combination with conventional therapies such as surgery, chemotherapy, and irradiation. Its UV1 is …
  • MicroPort Scientific Corp (853):医療機器:M&Aディール及び事業提携情報
    Summary MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co Ltd is a medical device company which develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, e …
  • Waterman Group Plc (WTM):企業の財務・戦略的SWOT分析
    Summary Waterman Group Plc (Waterman), formerly Waterman Partnership Holdings Plc, a subsidiary of CTI Engineering Co Ltd, is an engineering and environmental consultancy service provider that offers services for property, infrastructure, environment and energy markets. The company provides services …
  • China Sunshine Paper Holdings Company Limited:戦略・SWOT・企業財務分析
    China Sunshine Paper Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Sunshine Paper Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Municipal Energy Agency of Nebraska:企業の戦略的SWOT分析
    Municipal Energy Agency of Nebraska - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Shanghai Pharmaceutical Co Ltd (601607):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Pharmaceutical Co Ltd (Shanghai Pharma) is a manufacturer, retailer, wholesaler and distributor of healthcare products. The company carries out the research and development, manufacture and sale of pharmaceutical products for treating HER2 positive advanced breast cancer, systemic a …
  • FortisAlberta Inc.:企業の戦略的SWOT分析
    FortisAlberta Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Fabric Development Inc:企業の戦略的SWOT分析
    Fabric Development Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • NantKwest Inc (NK):製薬・医療:M&Aディール及び事業提携情報
    Summary NantKwest Inc (NantKwest), a subsidiary of NantWorks LLC, formerly Conkwest Inc, is a clinical-stage immunotherapy company that develops therapeutic treatments for cancer, infectious diseases, and inflammatory diseases. The company utilizes its immuno-oncology NK platform to destroy the tumo …
  • AVI Ltd:企業の戦略・SWOT・財務分析
    AVI Ltd - Strategy, SWOT and Corporate Finance Report Summary AVI Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Norsk Hydro ASA:企業のM&A・事業提携・投資動向
    Norsk Hydro ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Norsk Hydro ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Benihana Inc.:企業の戦略・SWOT・財務分析
    Benihana Inc. - Strategy, SWOT and Corporate Finance Report Summary Benihana Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • LRAD Corporation:戦略・SWOT・企業財務分析
    LRAD Corporation - Strategy, SWOT and Corporate Finance Report Summary LRAD Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Gencor Industries Inc (GENC):企業の財務・戦略的SWOT分析
    Gencor Industries Inc (GENC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • SKF AB:企業の戦略・SWOT・財務情報
    SKF AB - Strategy, SWOT and Corporate Finance Report Summary SKF AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • American Gene Technologies International Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary American Gene Technologies International Inc (AGT) is a drug development company that tests and commercializes gene-based drugs. The company develops therapies for the treatment of cancer, neurological disorders, AIDS, infectious diseases, Parkinson’s diseases, diabetes, familial dysautonomi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆